Eurizon Capital SGR SpA’s Avidity Biosciences RNAM Stock Holding History

Eurizon Capital SGR SpA’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,778	Closed	-$200K	–	1277
2025 Q4	$200K	Buy	+2,778	New	+$179K	﹤0.01%	652

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Eurizon Capital SGR SpA's RNAM Position: Q1 2026 in Review

Eurizon Capital SGR SpA sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 2,778 shares — an estimated $200K sold.

Eurizon Capital SGR SpA first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $200K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Eurizon Capital SGR SpA reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Eurizon Capital SGR SpA sold 2,778 Avidity Biosciences shares in Q1 2026, an estimated $200K.
Eurizon Capital SGR SpA first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Eurizon Capital SGR SpA's Avidity Biosciences position peaked at $200K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q1 2026, filed 8 May 2026.